| Financial Year |
March 31 2023 |
| Monetary Funds |
180,549,539.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,602,828.99 |
| Accounts Receivable |
160,022,761.13 |
| Advances to Suppliers |
11,343,133.62 |
| Other Receivables |
36,507,804.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
114,153,997.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,763,161.87 |
| Total Current Assets |
557,691,736.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
53,851,956.94 |
| Investment Properties |
-- |
| Fixed Assetes |
441,996,672.88 |
| Under-construction Projects |
102,423,183.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,248,579.34 |
| R&D expenses |
133,648,348.99 |
| Goodwill |
33,030,129.96 |
| Long-Term Deferred and Prepaid Expenses |
3,166,473.91 |
| Deferred Income Tax Assets |
26,187,068.36 |
| Other Non-Current Assets |
10,874,635.49 |
| Sub-Total of Non-Current Assets |
916,514,378.26 |
| Total Assets |
1,474,206,115.16 |
| Short-Term Loans |
209,118,002.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
135,688,112.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,801,128.39 |
| Taxes Payable |
34,063,291.82 |
| Interest Payable |
64,406,262.25 |
| Dividend Payable |
-- |
| Other payables |
289,437,327.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
304,058,965.19 |
| Other Current Liabilities |
10,438,342.07 |
| Sub-Total of Current Liabilities |
1,082,002,793.26 |
| Long-term Loans |
72,515,883.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
58,003,533.85 |
| Deferred Income Tax Liabilities |
5,854,447.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
169,232,745.47 |
| Total Liabilities |
1,251,235,538.73 |
| Paid-In Capital(Or Share Stock) |
416,689,834.00 |
| Capital Surplus |
617,751,045.96 |
| Surplus Reserve |
111,957,705.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-947,736,619.47 |
| Minority Stockholder's Interest |
44,070,829.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
178,899,747.20 |
| Owner's Equity（Stockholder's Equity） |
222,970,576.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,474,206,115.16 |
